Total: 3 |
|
PMID (PMCID) | ||
---|---|---|
22374528 |
MIXED_SAMPLE | |
[Marked improvement of anemia during treatment with deferasirox in patients with primary myelofibrosis and acute myeloid leukemia with myelodysplasia-related changes]. | ||
Matsuki E, Matsumoto K, Nakaya A, Yamane A, Kato J, Okamoto S. Rinsho Ketsueki. 2012;53(1):78-82. |
||
[Marked improvement of anemia during treatment with deferasirox in patients with primary myelofibrosis and acute myeloid leukemia with myelodysplasia-related changes]. | ||
16364769 |
MIXED_SAMPLE | Adult |
Cryptic 6p21.3 duplications and triplication involving HMGA1 partially masked by add 6p in four cases of myelodysplasia. | ||
Andrieux J, Geffroy S, Bilhou-Nabera C, Dupriez B, Demory JL, Bauters F, Lai JL, Dastugue N. Cancer Genet Cytogenet. 2006;164(1):84-7. |
||
High-mobility group AT-hook 2 (HMGA2) rearrangements have been described in myelofibrosis with myeloid metaplasia (MMM) and also in myelodysplasia. | ||
8285020 |
MIXED_SAMPLE | Adult |
Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis. | ||
Mohr B, Herrmann R, Huhn D. Acta Haematol. 1993;90(2):65-70. |
||
In a dose titration study we tested the efficacy and tolerance of recombinant human erythropoietin (rhEPO) in 10 patients with myelodysplasia (MDS) and 2 patients with idiopathic myelofibrosis. |